Kidney Cancer UK represents patients at NICE nivo+ipi appraisal
On 3rd February 2022, NICE approve the use of nivolumab with ipilimumab as a first line treatment for kidney cancer. This is... Read More
We would like to invite you to be kept up to date with news from the
charity by signing up to our newsletter. Please enter you email address below.
*By submitting your email address you are agreeing to us contacting you with news and appeals from Kidney Cancer
UK & Scotland. We will never share any of your information with any third parties.